VEGFA and neoplasm: We believed that one possible reason might be that the drugs used in traditional anti-angiogenic therapy tend to be anti-VEGF agents which play a role mainly by reducing endothelial cell proliferation or inducing endothelial cell apoptosis, while these drugs have little effect on vasculogenic mimicry (VM) formed by tumor cells.